elevated Lp(a) | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

328,081 results for “elevated Lp(a)”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

204 participants · First posted Jan 8, 2026

Active, not recruiting

SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)

144 participants · First posted Aug 4, 2026

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

42 participants · First posted Sep 16, 2014

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

10,450 participants · First posted Sep 5, 2025

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

340 participants · First posted Feb 7, 2025

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

320 participants · First posted Oct 4, 2022

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

422 participants · First posted Feb 20, 2024

Not yet recruiting

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events

120 participants · First posted Jul 27, 2026

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

70 participants · First posted Oct 28, 2020

Not yet recruiting

Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL

240 participants · First posted Jun 4, 2026

Page 1 of 27747